The iAtlas portal serves as an interactive tool for exploring and analyzing immuno-oncology data.
Consideration of the immune system is now fundamental to developing new therapeutic strategies for the treatment of cancer
The composition of the tumor microenvironment, including the types and quantity of immune cells, is predictive of clinical outcomes and treatment response
Researchers need access to tools and data for understanding patient responses and improving immunotherapy
This project is made possible through generous support of the Cancer Research Institute.
Immune Checkpoint Inhibitor Datasets
Cancer Genomics Datasets
The CRI iAtlas is a collaboration between the Cancer Research Institute, Sage Bionetworks, Institute for Systems Biology (ISB), and UNC Lineberger Comprehensive Cancer Center.
© 2024 CRI iAtlas